Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-d-glucose with positron emission tomography in patients with small cell lung cancer


Arslan N., Tuncel M., Kuzhan O., Alagoz E., Budakoglu B., Ozet A., ...Daha Fazla

ANNALS OF NUCLEAR MEDICINE, cilt.25, sa.6, ss.406-413, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 6
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1007/s12149-011-0478-y
  • Dergi Adı: ANNALS OF NUCLEAR MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.406-413
  • Anahtar Kelimeler: FDG-PET, Small cell lung cancer, Staging, Quantitative PET
  • Hacettepe Üniversitesi Adresli: Evet

Özet

The objective of this study is to determine whether 2-deoxy-2-[18F] fluoro-d-glucose with positron emission tomography (FDG-PET) imaging and quantitative PET parameters can predict outcome and differentiate patients with limited disease (LD) from extensive disease (ED) in patients with small cell lung cancer (SCLC).